Temporary anti-CD-25 treatment results in tolerance development in syngeneically grafted autoimmune diabetic recipients.
作者信息
Hahn H J, Kuttler B, Dunger A, Lucke S, Volk H D, Diamantstein T
机构信息
Institute of Immunology, Free University Berlin, Germany.
出版信息
Transplant Proc. 1991 Feb;23(1 Pt 1):741-2.
PMID:1990673
Abstract
摘要
相似文献
1
Temporary anti-CD-25 treatment results in tolerance development in syngeneically grafted autoimmune diabetic recipients.
Transplant Proc. 1991 Feb;23(1 Pt 1):741-2.
2
Effect of temporary IL-2 receptor MAB therapy on islet allograft in autoimmune diabetes.临时白细胞介素-2受体单克隆抗体疗法对自身免疫性糖尿病胰岛同种异体移植的影响。
Transplant Proc. 1989 Feb;21(1 Pt 3):2711-3.
3
Interleukin 2 receptor-targeted therapy in islet transplantation research.
Horm Metab Res Suppl. 1990;25:177-80.
4
Effect of anti-interleukin-2 receptor antibody treatment on recurrent autoimmune insulitis in the BB rat.
Transplant Proc. 1994 Apr;26(2):734-5.
5
Successful islet transplantation in BB rats without chronic immunosuppression.
Transplant Proc. 1987 Feb;19(1 Pt 2):974-5.
6
Temporary anti-CD25/CsA therapy induces a CD4+ T-cell-mediated tolerance in BB/OK rats.
J Autoimmun. 1996 Jun;9(3):321-9. doi: 10.1006/jaut.1996.0044.
7
Tolerance to islet xenografts induced by dual manipulation of antigen presentation and co-stimulation.
Transplant Proc. 1996 Apr;28(2):814-5.
8
9
Prevention of islet graft destruction in diabetic mice and rats by temporary anti-IL-2 receptor therapy: comparison of different strategies.
Transplant Proc. 1998 Dec;30(8):4140-2. doi: 10.1016/s0041-1345(98)01372-4.
10
Interleukin 2 receptor targeted immunotherapy in the prevention of autoimmune beta-cell destruction as observed in diabetic BB/OK rats grafted with BB/OK rat islets.
Autoimmunity. 1989;5(1-2):139-42. doi: 10.3109/08916938909029152.
Zotero 插件